S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Aileron Therapeutics Insider Trading Activity (NASDAQ:ALRN)

$0.42
-0.03 (-6.72 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$0.42
Now: $0.42
$0.45
50-Day Range
$0.43
MA: $0.71
$1.04
52-Week Range
$0.41
Now: $0.42
$2.70
Volume573,186 shs
Average Volume317,440 shs
Market Capitalization$11.58 million
P/E RatioN/A
Dividend YieldN/A
Beta2.3

Insider Trades

Aileron Therapeutics (NASDAQ:ALRN) Insider Buying and Selling Activity

Insider Ownership Percentage: 6.20%

Aileron Therapeutics (NASDAQ ALRN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2019Rickenbach Josef H VonDirectorBuy113,145$0.98$110,882.10
9/3/2019Rickenbach Josef H VonDirectorBuy28,466$0.72$20,495.5268,352  
8/29/2019Rickenbach Josef H VonDirectorBuy3,600$0.77$2,772.0053,352  
8/16/2019Vojo VukovicSVPBuy75,000$0.59$44,250.00  
8/13/2019Kathryn GregorySVPBuy45,000$0.65$29,250.00  
4/1/2019Bioventures Ltd NovartisMajor ShareholderSell127,150$1.86$236,499.00  
3/15/2019Bioventures Ltd NovartisMajor ShareholderSell190,338$2.06$392,096.28  
8/20/2018Bioventures Ltd NovartisMajor ShareholderSell20,388$2.30$46,892.40  
8/17/2018Bioventures Ltd NovartisMajor ShareholderSell17,508$2.10$36,766.80  
8/15/2018Bioventures Ltd NovartisMajor ShareholderSell5,935$2.21$13,116.35  
8/13/2018Bioventures Ltd NovartisMajor ShareholderSell7,215$2.42$17,460.30  
8/10/2018John P Phd LongeneckerInsiderBuy10,000$2.45$24,500.00  
8/9/2018Bioventures Ltd NovartisMajor ShareholderSell1,235$2.72$3,359.20  
8/7/2018Bioventures Ltd NovartisMajor ShareholderSell4,681$3.00$14,043.00  
8/1/2018Bioventures Ltd NovartisMajor ShareholderSell12,681$3.17$40,198.77  
7/30/2018Bioventures Ltd NovartisMajor ShareholderSell8,458$3.35$28,334.30  
7/26/2018Bioventures Ltd NovartisMajor ShareholderSell20,397$3.76$76,692.72  
7/24/2018Bioventures Ltd NovartisMajor ShareholderSell31,300$4.25$133,025.00  
7/17/2018Bioventures Ltd NovartisMajor ShareholderSell12,800$4.72$60,416.00  
6/26/2018Apple Tree Partners Ii LpMajor ShareholderSell106,257$5.92$629,041.44  
6/21/2018Apple Tree Partners Ii LpMajor ShareholderSell6,647$5.30$35,229.10  
6/19/2018Apple Tree Partners Ii LpMajor ShareholderSell9,532$5.32$50,710.24  
6/11/2018Apple Tree Partners Ii LpMajor ShareholderSell28,162$5.41$152,356.42  
6/8/2018Donald DoughertyCFOBuy3,000$5.40$16,200.00  
6/6/2018Manuel AivadoInsiderBuy1,000$5.61$5,610.00  
6/1/2018Donald DoughertyCFOBuy2,000$5.24$10,480.00  
4/19/2018Apple Tree Partners Ii LpMajor ShareholderSell107,904$6.31$680,874.24  
1/9/2018Apple Tree Partners Ii LpMajor ShareholderSell150,000$9.80$1,470,000.00  
7/5/2017Cvf, LlcMajor ShareholderBuy180,000$15.00$2,700,000.00  
7/5/2017Lilly Ventures Fund I LlcInsiderBuy250,000$15.00$3,750,000.00  
7/5/2017Reinhard J AmbrosDirectorBuy266,667$15.00$4,000,005.00  
(Data available from 1/1/2013 forward)
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Featured Article: Return on Investment (ROI)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel